Global Pharmacovigilance Market 2024-2028
Pharmacovigilance Market 2024-2028
The pharmacovigilance market is forecasted to grow by USD 2876.8 mn during 2023-2028, accelerating at a CAGR of 5.8% during the forecast period. The report on the pharmacovigilance market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing number of clinical trials.
Technavio's pharmacovigilance market is segmented as below:
By Service
- In-house
- Contract outsourcing
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the rising outsourcing of pharmacovigilance to cros as one of the prime reasons driving the pharmacovigilance market growth during the next few years. Also, integration of ai in pharmacovigilance and increasing approvals for new molecules and biosimilars will lead to sizable demand in the market.
The report on the pharmacovigilance market covers the following areas:
- Pharmacovigilance Market sizing
- Pharmacovigilance Market forecast
- Pharmacovigilance Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmacovigilance market vendors that include Accenture PLC, ArisGlobal LLC, Capgemini Services SAS, ClinChoice, Cognizant Technology Solutions Corp., eResearchTechnology GmbH, ICON plc, International Business Machines Corp., IQVIA Holdings Inc., ITClinical, Laboratory Corp. of America Holdings, Linical Co. Ltd., Medpace Holdings Inc., Parexel International Corp., SIRO Clinpharm Pvt. Ltd., Symogen Ltd., TAKE Solutions Ltd., Thermo Fisher Scientific Inc., United BioSource LLC, and Wipro Ltd.. Also, the pharmacovigilance market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.